{"disease":{"id":"hpv-infections","name":"hpv infections"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07200414","title":"Strengthening HPV Vaccination and Adolescent Health Research Program in Nigeria (SHARP)","phase":"NA","overall_status":"COMPLETED","enrollment_count":12654,"lead_sponsor_name":"Johns Hopkins Bloomberg School of Public Health","has_results":false},{"nct_id":"NCT07358910","title":"Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Institut Pasteur du Cambodge","has_results":false},{"nct_id":"NCT01086709","title":"Crossover Vaccination of Women Previously Randomized Into Protocol 04-C-N191","phase":"","overall_status":"COMPLETED","enrollment_count":5444,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT00943722","title":"A Study of V503 (A Multivalent Human Papillomavirus [HPV] L1 Virus-Like Particle [VLP] Vaccine) in Preadolescents and Adolescents (V503-002)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":3074,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT00834106","title":"Prevention of Human Papillomavirus (HPV) in 20 to 45 Year Old Chinese Women (V501-041)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":3006,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT05027776","title":"Immunogenicity and Safety of Quadrivalent HPV Vaccine in Healthy Chinese Female Subjects Aged 9 to 19 Years","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":1348,"lead_sponsor_name":"Shanghai Bovax Biotechnology Co., Ltd.","has_results":false},{"nct_id":"NCT04092257","title":"HPV-Based Screen-and-Treat Demonstration Project in Lilongwe","phase":"NA","overall_status":"COMPLETED","enrollment_count":1250,"lead_sponsor_name":"UNC Lineberger Comprehensive Cancer Center","has_results":true},{"nct_id":"NCT05372016","title":"Evaluate the Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1200,"lead_sponsor_name":"Shanghai Bovax Biotechnology Co., Ltd.","has_results":false},{"nct_id":"NCT00378560","title":"V501 Efficacy Study in Women Aged 18 to 26 (V501-027)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":1021,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT06002126","title":"Optimization of Cervical Cancer Screening Among Women Living With HIV in Latin American Countries","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1002,"lead_sponsor_name":"Weill Medical College of Cornell University","has_results":false},{"nct_id":"NCT05340322","title":"Identification and Treatment of Cervical Abnormalities in Perú Through Integration of Pocket Colposcopy and Telemedicine","phase":"NA","overall_status":"COMPLETED","enrollment_count":503,"lead_sponsor_name":"Duke University","has_results":true},{"nct_id":"NCT07244315","title":"Cervical Cancer Screening of Postmenopausal Women in Low- and Middle-income Countries Using HPV Self-sampling and Triage by Genotyping and Cytology","phase":"","overall_status":"COMPLETED","enrollment_count":500,"lead_sponsor_name":"University Hospital, Geneva","has_results":false},{"nct_id":"NCT04998318","title":"1:1 Comparison of the Pocket Colposcope in Kenya","phase":"NA","overall_status":"COMPLETED","enrollment_count":434,"lead_sponsor_name":"Duke University","has_results":true},{"nct_id":"NCT05996016","title":"Gut and Vaginal Microbiota Profile Study for HIV Women","phase":"","overall_status":"RECRUITING","enrollment_count":400,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT03391921","title":"Vaccination Against Human Papillomavirus (HPV) With the 9-valent Vaccine in HIV-positive Women (the Papillon Study)","phase":"PHASE4","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":170,"lead_sponsor_name":"Centre Hospitalier Universitaire Saint Pierre","has_results":false},{"nct_id":"NCT00682812","title":"Significance of the High-risk Hpv Viral Load","phase":"NA","overall_status":"COMPLETED","enrollment_count":149,"lead_sponsor_name":"Assistance Publique Hopitaux De Marseille","has_results":false},{"nct_id":"NCT07087145","title":"Feasibility of HPV Testing With Mail-delivered Sample Collection Kits","phase":"","overall_status":"RECRUITING","enrollment_count":135,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT00411749","title":"V501 Immunogenicity Study in Females Age 9 to 17 Years (V501-028)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":107,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT03900572","title":"A Study of Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":90,"lead_sponsor_name":"Shanghai Zerun Biotechnology Co.,Ltd","has_results":false},{"nct_id":"NCT07303751","title":"Study Assessing Reduced HPV Infectivity and Transmission in HPV-Positive Women Following Vaccination With 9vHPV","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":80,"lead_sponsor_name":"Institut d'Investigació Biomèdica de Bellvitge","has_results":false},{"nct_id":"NCT04155294","title":"Re-Evaluation of Annual Cytology Using HPV Testing to Upgrade Prevention in Women Living With HIV","phase":"","overall_status":"COMPLETED","enrollment_count":71,"lead_sponsor_name":"University of Oxford","has_results":false},{"nct_id":"NCT06672653","title":"Tolerance and Effectiveness of C14 on HPV Infection","phase":"PHASE1, PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":66,"lead_sponsor_name":"MGB Pharma","has_results":false},{"nct_id":"NCT07081334","title":"A Phase 1 Study of PV-001 9-valent Human Papillomavirus(HPV) Vaccine","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":41,"lead_sponsor_name":"POSVAX","has_results":false},{"nct_id":"NCT00733122","title":"Tolerability and Immunogenicity of Gardasil in Females Between 16 and 23 Years of Age in India (V501-034)","phase":"PHASE3","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":false}],"total":24},"guidelines":[],"source":"Drug Landscape verified database"}